Effect of Lactobacillus rhamnosus and Diclofenac with Curcumin for Neuronal
Restoration and Repair Against Scopolamine Induced Dementia in
Zebrafish (Danio rerio)

Sonal      Pande; Chirag      Patel

doi:10.2174/1573408019666230508155702

Abstract

Background: Clinical studies have already revealed the ubiquitous neuroprotective role of curcumin in neuronal deterioration, but it cannot be used alone due to its truncated bioavailability. Currently, many such approaches are functional, which overcome this issue either by increasing the solubility or absorption. These approaches carry a costlier treatment. One more tactic is present but less focused i.e., by limiting the intestine and liver enzymatic metabolism; by this approach, curcumin will be more available for its beneficial outcome.

Objective: The goal of this study was to evaluate the impact of Lactobacillus rhamnosus and diclofenac on the neuroprotective effects of curcumin against scopolamine-induced dementia.

Methods: Physical parameters involved a novel tank test, T maze test, whereas neurochemical parameters include brain oxidative stress and acetylcholinesterase (Ache) inhibition activity in a zebrafish dementia model.

Results: Our results demonstrated that curcumin with Lactobacillus rhamnosus and diclofenac significantly (p<0.05) reduced anxiety, memory deficits, and brain oxidative stress compared to the alone curcumin- treated group.

Conclusion: This result approves that curcumin with L.rhamnosus and diclofenac have superior activity compared to curcumin alone. However, further clinical studies are needed to validate these findings.

« Previous Next »

Graphical Abstract

[1]
Kametani F, Hasegawa M. Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer’s Disease. Front Neurosci  2018; 12: 25.
 [http://dx.doi.org/10.3389/fnins.2018.00025] [PMID:  29440986]

[2]
Chesser AS, Pritchard SM, Johnson GVW. Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease. Front Neurol  2013; 4: 122.
 [http://dx.doi.org/10.3389/fneur.2013.00122] [PMID:  24027553]

[3]
Weller J, Budson A. Current understanding of Alzheimer’s disease diagnosis and treatment. F1000 Res  2018; 7: 1161.
 [http://dx.doi.org/10.12688/f1000research.14506.1] [PMID:  30135715]

[4]
Kantipudi SJ, Sathianathan R. The dementia epidemic: Impact, prevention, and challenges for India. Indian J Psychiatry  2018; 60(2): 165-7.
 [http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_261_18] [PMID:  30166671]

[5]
Tang M, Taghibiglou C. The Mechanisms of Action of Curcumin in Alzheimer’s Disease. J Alzheimers Dis  2017; 58(4): 1003-16.
 [http://dx.doi.org/10.3233/JAD-170188] [PMID:  28527218]

[6]
Li HL, Liu C, de Couto G, et al. Curcumin prevents and reverses murine cardiac hypertrophy. J Clin Invest  2008; 118(3): 879-93.
 [http://dx.doi.org/10.1172/JCI32865] [PMID:  18292803]

[7]
Gupta SC, Kismali G, Aggarwal BB. Curcumin, a component of turmeric: From farm to pharmacy. Biofactors  2013; 39(1): 2-13.
 [http://dx.doi.org/10.1002/biof.1079] [PMID:  23339055]

[8]
Shahbaz SK, Koushki K, Sathyapalan T, Majeed M, Sahebkar A. PLGA-based curcumin delivery system: An interesting therapeutic approach in the treatment of alzheimer’s disease. Curr Neuropharmacol  2022; 20(2): 309-23.
 [http://dx.doi.org/10.2174/1570159X19666210823103020] [PMID:  34429054]

[9]
Pluta R. Furmaga-Jabłońska W, Januszewski S, Czuczwar SJ. Post-ischemic brain neurodegeneration in the form of Alzheimer’s disease proteinopathy: Possible therapeutic role of curcumin. Nutrients  2022; 14(2): 248.
 [http://dx.doi.org/10.3390/nu14020248] [PMID:  35057429]

[10]
Khurshid B, Rehman AU, Muhammad S, Wadood A, Anwar J. Toward the noninvasive diagnosis of Alzheimer’s disease: Molecular basis for the specificity of curcumin for fibrillar amyloid-β. ACS Omega  2022; 7(25): 22032-8.
 [http://dx.doi.org/10.1021/acsomega.2c02995] [PMID:  35785332]

[11]
Dib T, Pan H, Chen S. Recent advances in pectin-based nanoencapsulation for enhancing the bioavailability of bioactive compounds: Curcumin oral bioavailability. Food Rev Int  2022; 1-19.
 [http://dx.doi.org/10.1080/87559129.2021.2012796]

[12]
Jiang Z, Gan J, Wang L, Lv C. Binding of curcumin to barley protein Z improves its solubility, stability and bioavailability. Food Chem  2023; 399: 133952.
 [http://dx.doi.org/10.1016/j.foodchem.2022.133952] [PMID:  35998492]

[13]
Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: Problems and promises. Mol Pharm  2007; 4(6): 807-18.
 [http://dx.doi.org/10.1021/mp700113r] [PMID:  17999464]

[14]
Chhouk K. Wahyudiono, Kanda H, Kawasaki S-I, Goto M. Micronization of curcumin with biodegradable polymer by supercritical anti-solvent using micro swirl mixer. Front Chem Sci Eng  2018; 12(1): 184-93.
 [http://dx.doi.org/10.1007/s11705-017-1678-3]

[15]
Prasad S, Tyagi AK, Aggarwal BB. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res Treat  2014; 46(1): 2-18.
 [http://dx.doi.org/10.4143/crt.2014.46.1.2] [PMID:  24520218]

[16]
Abdel-Hafez SM, Hathout RM, Sammour OA. Curcumin-loaded ultradeformable nanovesicles as a potential delivery system for breast cancer therapy. Colloids Surf B Biointerfaces  2018; 167: 63-72.
 [http://dx.doi.org/10.1016/j.colsurfb.2018.03.051] [PMID:  29626721]

[17]
Xue J, Wang T, Hu Q, Zhou M, Luo Y. Insight into natural biopolymer-emulsified solid lipid nanoparticles for encapsulation of curcumin: Effect of loading methods. Food Hydrocoll  2018; 79: 110-6.
 [http://dx.doi.org/10.1016/j.foodhyd.2017.12.018]

[18]
Maleki Dizaj S, Alipour M, Dalir Abdolahinia E, et al. Curcumin nanoformulations: Beneficial nanomedicine against cancer. Phytother Res  2022; 36(3): 1156-81.
 [http://dx.doi.org/10.1002/ptr.7389] [PMID:  35129230]

[19]
Urošević M, Nikolić L, Gajić I, Nikolić V, Dinić A, Miljković V. Curcumin: Biological activities and modern pharmaceutical forms. Antibiotics (Basel)  2022; 11(2): 135.
 [http://dx.doi.org/10.3390/antibiotics11020135] [PMID:  35203738]

[20]
Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas P. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med  1998; 64(4): 353-6.
 [http://dx.doi.org/10.1055/s-2006-957450] [PMID:  9619120]

[21]
Hoehle SI, Pfeiffer E, Metzler M. Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases. Mol Nutr Food Res  2007; 51(8): 932-8.
 [http://dx.doi.org/10.1002/mnfr.200600283] [PMID:  17628876]

[22]
Rowland A, Miners JO, Mackenzie PI. The UDP-glucuronosyltransferases: Their role in drug metabolism and detoxification. Int J Biochem Cell Biol  2013; 45(6): 1121-32.
 [http://dx.doi.org/10.1016/j.biocel.2013.02.019] [PMID:  23500526]

[23]
Uchaipichat V, Mackenzie PI, Guo XH, et al. Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. Drug Metab Dispos  2004; 32(4): 413-23.
 [http://dx.doi.org/10.1124/dmd.32.4.413] [PMID:  15039294]

[24]
Kuehl GE, Lampe JW, Potter JD, Bigler J. Glucuronidation of nonsteroidal anti-inflammatory drugs: identifying the enzymes responsible in human liver microsomes. Drug Metab Dispos  2005; 33(7): 1027-35.
 [http://dx.doi.org/10.1124/dmd.104.002527] [PMID:  15843492]

[25]
Xie L, Ji X, Zhang Q, Wei Y. Curcumin combined with photodynamic therapy, promising therapies for the treatment of cancer. Biomed Pharmacother  2022; 146: 112567.
 [http://dx.doi.org/10.1016/j.biopha.2021.112567] [PMID:  34953392]

[26]
Ye Y, Zhang X, Chen X, et al. The use of widely targeted metabolomics profiling to quantify differences in medicinally important compounds from five Curcuma (Zingiberaceae) species. Ind Crops Prod  2022; 175: 114289.
 [http://dx.doi.org/10.1016/j.indcrop.2021.114289]

[27]
Joo J, Kim YW, Wu Z, et al. Screening of non-steroidal anti-inflammatory drugs for inhibitory effects on the activities of six UDP-glucuronosyltransferases (UGT1A1, 1A3, 1A4, 1A6, 1A9 and 2B7) using LC-MS/MS. Biopharm Drug Dispos  2015; 36(4): 258-64.
 [http://dx.doi.org/10.1002/bdd.1933] [PMID:  25522350]

[28]
Ozawa H, Imaizumi A, Sumi Y, et al. Curcumin β-D-Glucuronide Plays an Important Role to Keep High Levels of Free-Form Curcumin in the Blood. Biol Pharm Bull  2017; 40(9): 1515-24.
 [http://dx.doi.org/10.1248/bpb.b17-00339] [PMID:  28867734]

[29]
Wei B, Liu F, Liu X, et al. Enhancing stability and by-product tolerance of β-glucuronidase based on magnetic cross-linked enzyme aggregates. Colloids Surf B Biointerfaces  2022; 210: 112241.
 [http://dx.doi.org/10.1016/j.colsurfb.2021.112241] [PMID:  34847520]

[30]
Mina A, McNeice L, Banukumar S, Vazquez S. Optimisation of Benzodiazepine Immunoassay Using β-Glucuronidase Enzymatic Hydrolysis: A Comparison of Five Different β-Glucuronidase Enzymes. J Biosci Med  2022; 10(1): 7-15.

[31]
Pham PL, Dupont I, Roy D, Lapointe G, Cerning J. Production of exopolysaccharide by Lactobacillus rhamnosus R and analysis of its enzymatic degradation during prolonged fermentation. Appl Environ Microbiol  2000; 66(6): 2302-10.
 [http://dx.doi.org/10.1128/AEM.66.6.2302-2310.2000] [PMID:  10831403]

[32]
Biernat KA, Pellock SJ, Bhatt AP, et al. Structure, function, and inhibition of drug reactivating human gut microbial β-glucuronidases. Sci Rep  2019; 9(1): 825.
 [http://dx.doi.org/10.1038/s41598-018-36069-w] [PMID:  30696850]

[33]
Kim Y-H, Kim J-U, Oh S-J, Kim Y-J, Kim M-H, Kim S-H. Technical optimization of culture conditions for the production of exopolysaccharide (EPS) by lactobacillus rhamnosus ATCC 9595. Food Sci Biotechnol  2008; 17(3): 587-93.

[34]
Athari Nik Azm S, Djazayeri A, Safa M, et al. Lactobacilli and bifidobacteria ameliorate memory and learning deficits and oxidative stress in β-amyloid (1–42) injected rats. Appl Physiol Nutr Metab  2018; 43(7): 718-26.
 [http://dx.doi.org/10.1139/apnm-2017-0648] [PMID:  29462572]

[35]
Pande S, Patel C, Sarkar D, Acharya S. Lactobacillus rhamnosus UBLR-58 and diclofenac potentiate the anti- alzheimer activity of curcumin in mice. Curr Enzym Inhib  2021; 17(1): 49-56.
 [http://dx.doi.org/10.2174/1573408016999200817170821]

[36]
Patel C, Pande S, Acharya S. Potentiation of anti-Alzheimer activity of curcumin by probiotic Lactobacillus rhamnosus UBLR-58 against scopolamine-induced memory impairment in mice. Naunyn Schmiedebergs Arch Pharmacol  2020; 393(10): 1955-62.
 [http://dx.doi.org/10.1007/s00210-020-01904-3] [PMID:  32448977]

[37]
Newman M, Ebrahimie E, Lardelli M. Using the zebrafish model for Alzheimerâ€™s disease research. Front Genet  2014; 5: 189.
 [http://dx.doi.org/10.3389/fgene.2014.00189] [PMID:  25071820]

[38]
Lekchand Dasriya V, Samtiya M, Dhewa T, et al. Etiology and management of Alzheimer’s disease: Potential role of gut microbiota modulation with probiotics supplementation. J Food Biochem  2022; 46(1): e14043.
 [http://dx.doi.org/10.1111/jfbc.14043] [PMID:  34927261]

[39]
Liu C, Guo X, Chang X. Intestinal flora balance therapy based on probiotic support improves cognitive function and symptoms in patients with Alzheimer’s Disease: A systematic review and meta-analysis. Biomed Res Int  2022; 2022.
 [http://dx.doi.org/10.1155/2022/4806163]

[40]
Guzen FP, Neta FI, de Souza FES, Batista AL, Pinheiro FI, Cobucci RN. Effects of supplementation with probiotics in experimental models of Alzheimer’s disease: A systematic review of animal experiments. Curr Alzheimer Res  2022; 19(3): 188-201.
 [http://dx.doi.org/10.2174/1567205019666220318092003] [PMID:  35306987]

[41]
Sharma N, Khurana N, Muthuraman A. Lower vertebrate and invertebrate models of Alzheimer’s disease – A review. Eur J Pharmacol  2017; 815: 312-23.
 [http://dx.doi.org/10.1016/j.ejphar.2017.09.017] [PMID:  28943103]

[42]
Caramillo EM, Echevarria DJ. Alzheimer’s disease in the zebrafish: where can we take it? Behav Pharmacol  2017; 28(2 and 3): 179-86.
 [http://dx.doi.org/10.1097/FBP.0000000000000284] [PMID: 28177980]

[43]
Panula P, Sallinen V, Sundvik M, et al. Modulatory neurotransmitter systems and behavior: towards zebrafish models of neurodegenerative diseases. Zebrafish  2006; 3(2): 235-47.
 [http://dx.doi.org/10.1089/zeb.2006.3.235] [PMID:  18248264]

[44]
Cosacak MI, Bhattarai P, De Jager PL, Menon V, Tosto G, Kizil C. Single cell/nucleus transcriptomics comparison in zebrafish and humans reveals common and distinct molecular responses to Alzheimer’s disease. Cells  2022; 11(11): 1807.
 [http://dx.doi.org/10.3390/cells11111807] [PMID:  35681503]

[45]
Freeman JL, Kiper K. Use of zebrafish genetic models to study etiology of the amyloid-beta and neurofibrillary tangle pathways in Alzheimer’s disease. Curr Neuropharmacol  2022; 20(3): 524-39.
 [http://dx.doi.org/10.2174/1570159X19666210524155944] [PMID:  34030617]

[46]
Nery LR, Eltz NS, Hackman C, et al. Brain intraventricular injection of amyloid-β in zebrafish embryo impairs cognition and increases tau phosphorylation, effects reversed by lithium. PLoS One  2014; 9(9): e105862.
 [http://dx.doi.org/10.1371/journal.pone.0105862] [PMID:  25187954]

[47]
Stewart A, Gaikwad S, Kyzar E, Green J, Roth A, Kalueff AV. Modeling anxiety using adult zebrafish: A conceptual review. Neuropharmacology  2012; 62(1): 135-43.
 [http://dx.doi.org/10.1016/j.neuropharm.2011.07.037] [PMID:  21843537]

[48]
Wang Y, Huang H, Wu Q. Characterization of the zebrafish Ugt repertoire reveals a new class of drug-metabolizing UDP glucuronosyltransferases. Mol Pharmacol  2014; 86(1): 62-75.
 [http://dx.doi.org/10.1124/mol.113.091462] [PMID:  24728488]

[49]
Low SE, Amburgey K, Horstick E, et al. TRPM7 is required within zebrafish sensory neurons for the activation of touch-evoked escape behaviors. J Neurosci  2011; 31(32): 11633-44.
 [http://dx.doi.org/10.1523/JNEUROSCI.4950-10.2011] [PMID:  21832193]

[50]
Test No 203: Fish, Acute Toxicity Test, OECD Guidelines for the Testing of Chemicals.  Paris: OECD Publishing 2019; p. 1-24.

[51]
Gómez-Laplaza LM, Gerlai R. Latent learning in zebrafish (Danio rerio). Behav Brain Res  2010; 208(2): 509-15.
 [http://dx.doi.org/10.1016/j.bbr.2009.12.031] [PMID:  20043955]

[52]
Audira G, Sampurna B, Juniardi S, Liang ST, Lai YH, Hsiao CD. A simple setup to perform 3D locomotion tracking in zebrafish by using a single camera. Inventions (Basel)  2018; 3(1): 11.
 [http://dx.doi.org/10.3390/inventions3010011]

[53]
Thamaraikani T, Karnam M, Velapandian C. In silico docking of novel phytoalkaloid camalexin in the management of benomyl induced Parkinson’s disease and its in vivo evaluation by zebrafish model. CNS Neurol Disord Drug Targets  2022; 21(4): 343-53.
 [http://dx.doi.org/10.2174/1871527320666210903091447] [PMID:  34477539]

[54]
Richetti SK, Blank M, Capiotti KM, et al. Quercetin and rutin prevent scopolamine-induced memory impairment in zebrafish. Behav Brain Res  2011; 217(1): 10-5.
 [http://dx.doi.org/10.1016/j.bbr.2010.09.027] [PMID:  20888863]

[55]
Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem  1979; 95(2): 351-8.
 [http://dx.doi.org/10.1016/0003-2697(79)90738-3] [PMID:  36810]

[56]
Rukmini MS, D’Souza B, D’Souza V. Superoxide dismutase and catalase activities and their correlation with malondialdehyde in schizophrenic patients. Indian J Clin Biochem  2004; 19(2): 114-8.
 [http://dx.doi.org/10.1007/BF02894268] [PMID:  23105467]

[57]
Weydert CJ, Cullen JJ. Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nat Protoc  2010; 5(1): 51-66.
 [http://dx.doi.org/10.1038/nprot.2009.197] [PMID:  20057381]

[58]
Patel B, Sheth D, Vyas A, et al. Amelioration of intracerebroventricular streptozotocin-induced cognitive dysfunction by Ocimum sanctum L. through the modulation of inflammation and GLP-1 levels. Metab Brain Dis  2022; 37(7): 2533-43.
 [http://dx.doi.org/10.1007/s11011-022-01056-8] [PMID:  35900690]

[59]
Karlinsky H. Alzheimer’s disease in Down’s syndrome. A review. J Am Geriatr Soc  1986; 34(10): 728-34.
 [http://dx.doi.org/10.1111/j.1532-5415.1986.tb04304.x] [PMID:  2944942]

[60]
Glenner GG, Wong CW. Alzheimer’s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun  1984; 120(3): 885-90.
 [http://dx.doi.org/10.1016/S0006-291X(84)80190-4] [PMID:  6375662]

[61]
Spencer DG Jr, Lal H. Effects of anticholinergic drugs on learning and memory. Drug Dev Res  1983; 3(6): 489-502.
 [http://dx.doi.org/10.1002/ddr.430030602]

[62]
Chen KC, Baxter MG, Rodefer JS. Central blockade of muscarinic cholinergic receptors disrupts affective and attentional set-shifting. Eur J Neurosci  2004; 20(4): 1081-8.
 [http://dx.doi.org/10.1111/j.1460-9568.2004.03548.x] [PMID:  15305877]

[63]
Tsukada H, Nishiyama S, Fukumoto D, Ohba H, Sato K, Kakiuchi T. Effects of acute acetylcholinesterase inhibition on the cerebral cholinergic neuronal system and cognitive function: Functional imaging of the conscious monkey brain using animal PET in combination with microdialysis. Synapse  2004; 52(1): 1-10.
 [http://dx.doi.org/10.1002/syn.10310] [PMID:  14755627]

[64]
Hamilton TJ, Morrill A, Lucas K, et al. Establishing zebrafish as a model to study the anxiolytic effects of scopolamine. Sci Rep  2017; 7(1): 15081.
 [http://dx.doi.org/10.1038/s41598-017-15374-w] [PMID:  29118373]

[65]
Huo X, Tian X, Li Y, et al. A highly selective ratiometric fluorescent probe for real-time imaging of β-glucuronidase in living cells and zebrafish. Sens Actuators B Chem  2018; 262: 508-15.
 [http://dx.doi.org/10.1016/j.snb.2018.02.047]

[66]
Gao X, Zhang P, Chen J, et al. Necrostatin-1 Relieves Learning and Memory Deficits in a Zebrafish Model of Alzheimer’s Disease Induced by Aluminum. Neurotox Res  2022; 40(1): 198-214.
 [http://dx.doi.org/10.1007/s12640-021-00463-6] [PMID:  34982355]

[67]
Barthelson K, Newman M, Lardelli M. Brain transcriptomes of zebrafish and mouse Alzheimer’s disease knock-in models imply early disrupted energy metabolism. Dis Model Mech  2022; 15(1): dmm049187.
 [http://dx.doi.org/10.1242/dmm.049187] [PMID:  34842276]

[68]
Todirascu-Ciornea E, El-Nashar HAS, Mostafa NM, et al. Schinus terebinthifolius essential oil attenuates scopolamine-induced memory deficits via cholinergic modulation and antioxidant properties in a zebrafish model.  Evidence-Based Complement Altern Med 2019; p. 2019.

[69]
Saleem S, Kannan RR. Zebrafish: An emerging real-time model system to study Alzheimer’s disease and neurospecific drug discovery. Cell Death Discov  2018; 4(1): 45.
 [http://dx.doi.org/10.1038/s41420-018-0109-7] [PMID:  30302279]

[70]
de Abreu MS, Giacomini ACVV, Sysoev M, et al. Modeling gut-brain interactions in zebrafish. Brain Res Bull  2019; 148: 55-62.
 [http://dx.doi.org/10.1016/j.brainresbull.2019.03.003] [PMID:  30890360]

[71]
Bashirzade AA, Zabegalov KN, Volgin AD, et al. Modeling neurodegenerative disorders in zebrafish. Neurosci Biobehav Rev  2022; 138: 104679.
 [http://dx.doi.org/10.1016/j.neubiorev.2022.104679] [PMID:  35490912]

[72]
Decker AL, Duncan K. Acetylcholine and the complex interdependence of memory and attention. Curr Opin Behav Sci  2020; 32: 21-8.
 [http://dx.doi.org/10.1016/j.cobeha.2020.01.013]

[73]
Záborszky L, Gombkoto P, Varsanyi P, et al. Specific basal forebrain–cortical cholinergic circuits coordinate cognitive operations. J Neurosci  2018; 38(44): 9446-58.
 [http://dx.doi.org/10.1523/JNEUROSCI.1676-18.2018] [PMID:  30381436]

[74]
Quinlivan VH, Farber SA. Lipid uptake, metabolism, and transport in the larval zebrafish. Front Endocrinol  2017; 8: 319.
 [http://dx.doi.org/10.3389/fendo.2017.00319] [PMID:  29209275]

[75]
Telles-Longui M, Mourelle D, Schöwe NM, et al. α7 nicotinic ACh receptors are necessary for memory recovery and neuroprotection promoted by attention training in amyloid‐β‐infused mice. Br J Pharmacol  2019; 176(17): bph.14744.
 [http://dx.doi.org/10.1111/bph.14744] [PMID: 31144293]

[76]
Basaure P, Guardia-Escote L, Cabré M, et al. Learning, memory and the expression of cholinergic components in mice are modulated by the pesticide chlorpyrifos depending upon age at exposure and apolipoprotein E (APOE) genotype. Arch Toxicol  2019; 93(3): 693-707.
 [http://dx.doi.org/10.1007/s00204-019-02387-9] [PMID:  30656380]

[77]
Patel C, Shukla P, Pande S, Punamiya R, Ranch K, Boddu SHS. Acute and sub-acute toxicity study of anti-obesity herbal granules in Sprague Dawley rats. Braz J Biol  2024; 84: e264320.
 [http://dx.doi.org/10.1590/1519-6984.264320] [PMID:  35946729]

[78]
Chavda VP, Anand K, Patel C, et al. Therapeutic approaches to amyotrophic lateral sclerosis from the lab to the clinic. Curr Drug Metab  2022; 23(3): 200-22.
 [http://dx.doi.org/10.2174/1389200223666220310113110] [PMID:  35272595]

Rights & Permissions Print Cite

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/1573408019666230508155702	Print ISSN 1573-4080
Publisher Name Bentham Science Publisher	Online ISSN 1875-6662

Current Enzyme Inhibition

Effect of Lactobacillus rhamnosus and Diclofenac with Curcumin for Neuronal Restoration and Repair Against Scopolamine Induced Dementia in Zebrafish (Danio rerio)

Abstract Play Pause

Graphical Abstract

Related Books

Abstract